New Delhi, March 9 Mumbai-based True North divested a 3.6 per cent stake in Anthem Biosciences for Rs 1,261 crore through a transaction in the open market on Monday.
Private equity firm True North, through its affiliate Viridity Tone LLP, sold a total of 2,03,13,795 shares, representing a 3.62 per cent stake in Bengaluru-based Anthem Biosciences, according to bulk deal data on the BSE.
The shares were sold at an average price of Rs 621.11 per share, making the deal worth Rs 1,261.71 crore.
As of the end of the December 2025 quarter, Viridity Tone LLP held 3.80 per cent in Anthem Biosciences.
Meanwhile, HDFC Mutual Fund (MF) and SBI MF collectively acquired 93,01,020 shares, or a 1.65 per cent stake, in Anthem Biosciences at an average price of Rs 621.10 per share.
This brought the combined deal value to Rs 577.68 crore.
Other buyers of Anthem Biosciences' shares could not be ascertained on the exchange.
Shares of Anthem Biosciences fell slightly to close at Rs 660 per share on the BSE.
Anthem Biosciences is a fully integrated contract research, development, and manufacturing organization.